Sufferers with PSMA-positive metastatic castration-resistant prostate most cancers in a part 3 trial confirmed optimistic outcomes after receiving 177Lu-PSMA-I&T.Remedy with 177Lu-PSMA-I&T in sufferers...
In sufferers ineligible for platinum-based chemotherapy with superior bladder most cancers, preliminary Keytruda could also be necessary. Amongst sufferers with superior bladder carcinoma...
Magrolimab plus docetaxel improved outcomes in sufferers with metastatic NSCLC and excessive CD47 expression, based on a examine.Improved outcomes had been seen with...
